227 related articles for article (PubMed ID: 19214153)
1. Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.
Prokai-Tatrai K; Prokai L
Molecules; 2009 Feb; 14(2):633-54. PubMed ID: 19214153
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel, centrally-acting thyrotropin-releasing hormone analogues.
Prokai-Tatrai K; Perjési P; Zharikova AD; Li X; Prokai L
Bioorg Med Chem Lett; 2002 Aug; 12(16):2171-4. PubMed ID: 12127530
[TBL] [Abstract][Full Text] [Related]
3. Prodrug design for brain delivery of small- and medium-sized neuropeptides.
Prokai-Tatrai K; Prokai L
Methods Mol Biol; 2011; 789():313-36. PubMed ID: 21922418
[TBL] [Abstract][Full Text] [Related]
4. A pyridinium-substituted analog of the TRH-like tripeptide pGlu-Glu-Pro-NH2 and its prodrugs as central nervous system agents.
Prokai-Tatrai K; Teixido M; Nguyen V; Zharikova AD; Prokai L
Med Chem; 2005 Mar; 1(2):141-52. PubMed ID: 16787309
[TBL] [Abstract][Full Text] [Related]
5. Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue.
Prokai L; Prokai-Tatrai K; Ouyang X; Kim HS; Wu WM; Zharikova A; Bodor N
J Med Chem; 1999 Nov; 42(22):4563-71. PubMed ID: 10579819
[TBL] [Abstract][Full Text] [Related]
6. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
7. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
Prokai L; Prokai-Tatrai K; Zharikova AD; Nguyen V; Perjesi P; Stevens SM
J Med Chem; 2004 Nov; 47(24):6025-33. PubMed ID: 15537357
[TBL] [Abstract][Full Text] [Related]
8. Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.
Bundgaard H; Møss J
Pharm Res; 1990 Sep; 7(9):885-92. PubMed ID: 2122435
[TBL] [Abstract][Full Text] [Related]
9. Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2.
Prokai-Tatrai K; Nguyen V; Zharikova AD; Braddy AC; Stevens SM; Prokai L
Bioorg Med Chem Lett; 2003 Mar; 13(6):1011-4. PubMed ID: 12643900
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system effects of thyrotropin-releasing hormone and its analogues: opportunities and perspectives for drug discovery and development.
Prokai L
Prog Drug Res; 2002; 59():133-69. PubMed ID: 12458966
[TBL] [Abstract][Full Text] [Related]
11. Prodrug strategy for enhanced therapy of central nervous system disease.
Xia X; Zhou Y; Gao H
Chem Commun (Camb); 2021 Sep; 57(71):8842-8855. PubMed ID: 34486590
[TBL] [Abstract][Full Text] [Related]
12. A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
Hichens M
Drug Metab Rev; 1983; 14(1):77-98. PubMed ID: 6301791
[No Abstract] [Full Text] [Related]
13. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.
Kaur N; Lu X; Gershengorn MC; Jain R
J Med Chem; 2005 Sep; 48(19):6162-5. PubMed ID: 16162016
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability.
Metcalf G; Dettmar PW; Lynn AG; Brewster D; Havler ME
Regul Pept; 1981 Sep; 2(5):277-84. PubMed ID: 6795691
[TBL] [Abstract][Full Text] [Related]
15. [β-Glu
Prokai-Tatrai K; Nguyen V; Prokai L
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207724
[TBL] [Abstract][Full Text] [Related]
16. Modifying peptide properties by prodrug design for enhanced transport into the CNS.
Prokai-Tatrai K; Prokai L
Prog Drug Res; 2003; 61():155-88. PubMed ID: 14674612
[No Abstract] [Full Text] [Related]
17. Exploratory neuropharmacological evaluation of a conformationally constrained thyrotropin-releasing hormone analogue.
Teixidó M; Prokai-Tatrai K; Wang X; Nguyen V; Prokai L
Brain Res Bull; 2007 Jun; 73(1-3):103-7. PubMed ID: 17499643
[TBL] [Abstract][Full Text] [Related]
18. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.
Hinkle PM; Pekary AE; Senanayaki S; Sattin A
Brain Res; 2002 May; 935(1-2):59-64. PubMed ID: 12062473
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.
Scalabrino GA; Hogan N; O'Boyle KM; Slator GR; Gregg DJ; Fitchett CM; Draper SM; Bennett GW; Hinkle PM; Bauer K; Williams CH; Tipton KF; Kelly JA
Neuropharmacology; 2007 Jun; 52(7):1472-81. PubMed ID: 17418282
[TBL] [Abstract][Full Text] [Related]
20. Neurologically active peptides.
Barbeau A; Gonce M; Kastin AJ
Pharmacol Biochem Behav; 1976; 5(Suppl 1):159-63. PubMed ID: 13415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
